Læknablaðið - 15.12.1989, Síða 23

LÆKNABLAÐIÐ
395
14. Sigfússon S. Hlutur geðsjúkra í heilbrigðisþjónustu
annarri en geðlæknisþjónustu. Læknablaðið 1981; 67:
50-64.
15. Njálsson Þ. Samanburður skráninga samskipta á fimm
heilsugæslustöðum. Læknablaðið 1988; 74; 319-24.
16. Sigurðsson G, Magnússon G, Sigvaldason H &
al. Egilsstaðaannsóknin. Heilbrigðisskýrslur 1980;
fylgirit 1. Reykjavík: Landlæknisembættið 1980.
17. Helgason T. Prevalence and incidence of mental
disorders estimated by a health questionnaire and a
psychiatric case register. Acta Psychiatr Scand 1978;
58: 256-66.
18. Helgason T. Some remarks on psychiatric
epidemiology in Europe. Bíður birtingar í Psychiatrie
& Psychobiologie 1989.
19. Norska lakemedelsnámnden. Nordisk
lákemedelsstatistik 1981-1983. Uppsala: NLN
Publikation, 1986; 14.
20. Murray J, Dunn G, Williams P, Tamopolsky A.
Factors affecting the consumption of psychotropic
dmgs. Psychol Med 1981; 11: 551-60.
21. Siciliani O, Bellantuono C, Williams P, Tansella M.
Self-reported use of psychotropic dmgs and alcohol
abuse in South-Verona. Psychol Med 1985; 15: 821-
6.
22. Uhlenhuth EH, Balter MB, Lipman RS. Minor
Tranquilizers; Clinical Correlates of Use in an Urban
Population. Arch Gen Psychiatry 1978; 35: 650-5.
23. Riska E, Klaukka T. Use of Psychotropic Dmgs in
Finland. Soc Sci Med 1984; 19: 983-9.
24. Williams P, Murray J, Clare A. A longitudinal study
of psychotropic dmg prescription. Psychol Med 1982;
12:201-6.
25. Mellinger GD, Balter MB, Eberhard H, Uhlenhuth
EH. Prevalence and Correlates of the Long-term
Regular Use of Anxiolytics. JAMA 1984; 251: 375-9.
26. Rodrigo EK, King MB, Williams P. Health of long
term benzodiazepine users. Br Med J 1988; 296: 603-
6.
27. Riska E. How the Sex Differences in the Use of
Psychotropic Dmgs Are Explained. Scand J Soc Med
1989; 17: 3-6.
28. Goldberg D. The detection of psychiatric illness by a
questionnaire. London: Oxford University Press 1972.
29. Stefánsson JG, Kristjánsson 1. Athugun á
greiningarhæfni tveggja spumingalista notaðra við
hóprannsóknir í geðlæknisfræði. Læknablaðið 1983;
fylgirit 13: 27-31.
30. Helgason T. Afengisneysluvenjur og einkenni um
misnotkun 1974 og 1984. Læknablaðið 1988; 74:
129-36.
31. Hagstofa Islands. Mannfjöldi 1. desember 1984 eftir
kyni, aldri og hjúskaparstétt. Reykjavík: Hagtíðindi
1985; 70:1: 24-7.
32. Norusis, MJ. SPSS/PC+ V2.0 Base Manual. SPSS
Inc. Chicago 1988; B 165-75, C 17-21.
33. Helgason T. Alkoholmisbmgets epidemiologi. Nord
Med 1984; 99: 290-3.
34. Helgason T. Neurosemes og alkoholismens
epidemiologi. Nord Psykiatr Tidsskr 1970; 24: 28-
44.
35. Bergdahl U, Hansson H-B, Kaij L, Melander A,
Olovsson L. Anxiolytika - hypnotika i öppen várd
- omfattningen av bmk och misbmk. Lákartidningen
1984; 81: 3690-2.
36. Grímsson A, Olafsson O. Lyfjaávísanir í Reykjavík.
Tímarit um lyfjafræði 1975; 10: 21-7.
37. Helgason T. Algengi notkunar róandi lyfja og
verkjalyfja árið 1988. Læknablaðið, Fréttabréf lækna
1989; 7 (4); 20-1.
38. Consensus dokument: Behandling ved depressions
sjukdommar. Lákartidningen 1984; 81: 763-6.
39. Regier DA. The NIMH D/ART Program - Research
foundations. Paper presented at symposium on
Epidemiology and Prevention of Mental Disorders
organized by World Psychiatric Association, Section
of Epidemiology and Community Psychiatry in
Reykjavík 1987.
40. Williams P, Gabe J. Tranquillizer use: Epidemiolgical
and sociological aspects. I: Williams P, Wilkinson G,
Rawnsley K (eds.). The Scope of Epidemiological
Psychiatry. London: Rutledge, 1989; 328-42.
41. Lader M. Long-term benzodiazepine use and
psychological functioning. I: Freeman H, Rye
Y (eds.) The benzodiazepines in current clinical
practice. London: Royal Society of Medicine 1987,
55-69.
42. Rickles K, Schweizer E, Lucki I. Benzodiazepine
side effects. í: Hales RE, Francis AJ (eds.) Annual
Review 1987; 6:781-801. Washington DC: American
Psychiatric Press.
43. Tyrer P. Benefits and risks of benzodiazepines. I:
Freeman H, Rye Y (eds.). The Benzodiazepines in
Current Clinical Practice. London: Royal Society of
Medicine 1987: 3-11.
44. Rickles K, Schweizer E. Psychiatric indications
for benzodiazepines. I: Freeman H, Rye Y (eds.).
The Benzodiazepines in Current Clinical Practice.
London; Royal Society of Medicine, 1987, 35-41.
45. Greenblatt DJ, Shader RI, Abemathy DR. Current
status of benzodiazepines. N Eng J Med 1983; 309:
354-8 og 410-16.
46. Tyrer P. Risks of dependence on benzodiazepine
dmgs: The importance of patient selection. Br Med
J 1989; 298: 102-5.
47. Marks J. Techniques of benzodiazepine withdrawal
in clinical practice. A consensus workshop report.
Medical Toxicology 1988; 3: 324-33.